Form 4: Precigen CCO Phil Tennant Exercises 62,500 RSUs

Chief Commercial Officer Phil Tennant acquired 62,500 shares of Precigen common stock through the vesting of restricted stock units.

Summary

• Phil Tennant, Chief Commercial Officer of Precigen, Inc., acquired 62,500 shares of common stock on May 23, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs) granted on June 26, 2025.
• Following this transaction, Tennant's total beneficial ownership of Precigen common stock increased to 169,641 shares.
• The remaining RSUs from the original grant are scheduled to vest in equal quarterly installments over the next three years.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation and does not indicate a change in company strategy or financial outlook.

Positives

• The transaction reflects the vesting of equity compensation, aligning the executive's interests with long-term shareholder value.

Negatives

• None identified in this filing.

Risks

• The value of the acquired shares is subject to market volatility and the future performance of Precigen, Inc.

Future Outlook

The remaining RSUs from the June 2025 grant will continue to vest in equal quarterly installments over the next three years.

Industry Context

StockSavvy.ai notes that executive equity vesting is a standard corporate governance practice in the biotechnology sector, serving as a retention tool for key leadership personnel.

Comparison to Industry Standards

• The vesting schedule and equity compensation structure are consistent with standard practices for C-suite executives in mid-cap biotechnology firms.

Stakeholder Impact

• Increased share ownership by the Chief Commercial Officer may be viewed positively by shareholders as a sign of confidence in the company's long-term prospects.

Next Steps

• Quarterly vesting of remaining restricted stock units over the next three years.

Key Dates

Keywords

Precigen, PGEN, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units